Intra-Cellular Therapies, Inc. (ITCI)

2 members of Congress have disclosed 5 trades in Intra-Cellular Therapies, Inc. (ITCI) via STOCK Act filings. The most recent disclosure was a sale by Gilbert Cisneros on 3 April 2025. The most active traders have been Roger Marshall (3) and Gilbert Cisneros (2). Aggregate disclosed activity totals roughly $24K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for ITCI
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for ITCI

5 transactions
Compliance: 40%
Gilbert Cisneros3 Apr 20256 May 2025SaleStock$1,001 - $15,000N/A
Gilbert Cisneros24 Mar 20257 Apr 2025SaleStock$1,001 - $15,000N/A
Roger Marshall1 May 20176 Aug 2018PurchaseStock$1,001 - $15,000N/A
Roger Marshall1 May 201713 Aug 2020PurchaseStock$1,001 - $15,000N/A
Roger Marshall1 May 201710 Aug 2018PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$14.05B

Volume

16.04M

Beta

0.46

P/E Ratio

-180.64

Fundamentals

EPS

$-0.73

Div. Yield

-

Open

$131.87

Day Range

$131.87 – $131.87

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ · USD
Country
US
CEO
Sharon Mates
IPO Date
2014-01-07
Website
www.intracellulartherapies.com

Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on creating innovative treatments for conditions affecting the brain and nervous system. The company achieves this by targeting the intricate cellular communication pathways within...

Earnings

Recent Quarters

Q4 202421 Feb
EPS$-0.16
Miss 100.0%
Q3 202430 Oct
EPS$-0.25
Miss 38.9%
Q2 20247 Aug
EPS$-0.16
Beat 11.1%
Q1 20247 May
EPS$-0.16
Beat 48.4%
Q4 202322 Feb
EPS$-0.30
Beat 31.8%
Q3 20232 Nov
EPS$-0.25
Beat 57.6%
Q2 20233 Aug
EPS$-0.45
Beat 27.4%
Q1 20234 May
EPS$-0.46
Beat 27.0%
Q4 20221 Mar
EPS$-0.45
Beat 27.4%
Q3 20223 Nov
EPS$-0.57
Beat 33.7%
Q2 20229 Aug
EPS$-0.92
Miss 16.5%
Q1 202210 May
EPS$-0.78
Beat 16.1%
Q4 20211 Mar
EPS$-1.05
Beat 0.0%
Q3 20219 Nov
EPS$-0.95
Miss 6.7%
Q2 20219 Aug
EPS$-0.85
Miss 7.6%
Q1 202110 May
EPS$-0.65
Beat 19.8%
Q4 202025 Feb
EPS$-0.76
Beat 10.6%
Q3 20209 Nov
EPS$-0.79
Beat 17.7%
Q2 202010 Aug
EPS$-0.96
Miss 2.1%
Q1 20207 May
EPS$-0.73
Beat 25.5%
Q4 20192 Mar
EPS$-0.74
Beat 6.3%
Q3 20195 Nov
EPS$-0.63
Beat 26.7%
Q2 20197 Aug
EPS$-0.68
Beat 25.3%
Q1 20198 May
EPS$-0.63
Beat 30.0%
Q4 201827 Feb
EPS$-0.75
Beat 10.7%
Q3 20187 Nov
EPS$-0.76
Beat 10.6%
Q2 20182 Aug
EPS$-0.68
Beat 11.7%
Q1 20183 May
EPS$-0.65
Beat 0.0%
Q4 20171 Mar
EPS$-0.56
Miss 12.0%
Q3 20178 Nov
EPS$-0.53
Beat 8.6%
Q2 20179 Aug
EPS$-0.41
Beat 44.6%
Q1 201710 May
EPS$-0.62
Beat 16.2%
Q4 20161 Mar
EPS$-0.64
Beat 16.9%
Q3 20169 Nov
EPS$-0.70
Beat 16.7%
Q2 20164 Aug
EPS$-0.71
Beat 10.1%
Q1 201628 Apr
EPS$-0.64
Beat 14.7%
Q4 201525 Feb
EPS$-0.67
Beat 20.2%
Q3 20155 Nov
EPS$-0.91
Miss 37.9%
Q2 20155 Aug
EPS$-0.61
Beat 17.6%
Q1 201530 Apr
EPS$-0.72
Miss 5.9%
Q4 201412 Mar
EPS$-0.52
Miss 6.1%
Q3 20143 Nov
EPS$-0.22
Beat 35.3%
Q2 201412 Aug
EPS$-0.15
Beat 37.5%
Q1 20145 May
EPS$-0.17
Beat 29.2%
Q4 201325 Mar
EPS$-0.30
Q3 20135 Nov
EPS$-0.22
Q2 201314 Aug
EPS$-0.00
Q2 201316 Jul
EPS$-0.39
Q3 201231 Dec
EPS$-0.21

3 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ITCI

Which members of Congress have traded ITCI?
2 members of Congress have disclosed 5 trades in Intra-Cellular Therapies, Inc. (ITCI) under the STOCK Act. The most active traders are Roger Marshall and Gilbert Cisneros.
When was ITCI most recently disclosed by Congress?
The most recent ITCI disclosure was a sale by Gilbert Cisneros on 3 April 2025.
What is the total disclosed congressional trading volume for ITCI?
Members of Congress have disclosed approximately $24K in ITCI purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ITCI?
This ITCI page updates as soon as new STOCK Act disclosures are filed for Intra-Cellular Therapies, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.